Beyond diagnosis: What biomarkers are teaching us about the “bio”logy of Alzheimer disease


  • Gil D. Rabinovici MD,

    1. Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, CA
    2. Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA
    Search for more papers by this author
  • Erik D. Roberson MD, PhD

    1. Center for Neurodegeneration and Experimental Therapeutics, Alzheimer's Disease Center, Departments of Neurology and Neurobiology, University of Alabama at Birmingham, Birmingham, AL
    Search for more papers by this author

No abstract is available for this article.